Rituximab for the first-line treatment of stage III IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.

Source:
NIHR Journals Library - Health Technology Assessment
Publisher:
NIHR Journals Library – Health Technology Assessment
Publication date:
01 October 2012

Abstract

(2012) Rituximab for the first-line treatment of stage III IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.. NIHR Journals Library - Health Technology Assessment: Health Technology Assessment (HTA) publishes research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. Find out more about the HTA journal at https://www.journalslibrary.nihr.ac.uk/hta/#/.